Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 7Recruiting 4Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 23Thoracic 8Genitourinary 7Gynecologic 6Breast 6Lymphoid 5Head & Neck 5Sarcoma 4Dermatologic 4CNS 4Tumor-Agnostic 3Other hematologic neoplasm 3Other solid neoplasm 2Other 2Plasma cell 1Myeloid 1Endocrine 1

Conditions

Meningioma 2Glioma 1Cardiotoxicity 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 78Magnetic Resonance Spectroscopy 69Specimen Handling 45Radiotherapy 42Bevacizumab 28Radiosurgery 27Cyclophosphamide 27pembrolizumab 20Radiation 20Blood Specimen Collection 19fludarabine 16Nivolumab 16Irinotecan 14Carboplatin 13Biopsy 13Etoposide 12Vincristine 11Pemetrexed 11Lomustine 11Surgical Procedures, Operative 9trametinib 8dinutuximab 8abemaciclib 8Ipilimumab 8Fluorodeoxyglucose F18 8naxitamab 7fluciclovine F-18 7Watchful Waiting 7Topotecan 7Proton Therapy 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Observation × CNS × Clear all
NCT03180268 2026-05-07

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

NRG Oncology

Phase 3 Recruiting
163 enrolled
CNS

Meningioma

NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting
10 enrolled
CNS

Glioma

NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

SWOG Cancer Research Network

Phase 3 Recruiting
491 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting
136 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡